![](https://imgproxy.divecdn.com/gyKwY3yDWI0Q6IU376xBm-dniQTT1TB1mRZUi7ZzCZE/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMDA3ODk0NDcwX0tUS3BkSlguanBn.webp)
‘It’s not for the faint of heart.’ How 3 CEOs took their biotechs public
Drug development is a notoriously expensive business. Discovering, testing and advancing a medicine can cost hundreds of millions of dollars, putting immense pressure on young biotechnology companies to be on constant lookout for new sources of funding. …